These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30289661)

  • 1. [The clinical significance of insulin resistance, impaired carbohydrate and lipid metabolism in the development of microcirculation pathology in patients with chronic heart failure and type 2 diabetes mellitus].
    Statsenko ME; Turkina SV; Shilina NN; Kosivtsova MA
    Klin Med (Mosk); 2016; 94(6):439-44. PubMed ID: 30289661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of diabetes on heart failure: opportunities for intervention.
    Skouri HN; Tang WH
    Curr Heart Fail Rep; 2007 Jun; 4(2):70-7. PubMed ID: 17521498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ASSESSING THE IMPACT OF CARDIAC DYSSYNCHRONY ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEART FAILURE IN COMBINATION WITH TYPE 2 DIABETES MELLITUS].
    Vlasenko MA; Rodionova IuV; Lopin DO
    Lik Sprava; 2014; (7-8):46-50. PubMed ID: 26118081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of antioxidant activity of nebivolol in patients with chronic heart failure with and without concomitant type 2 diabetes].
    Belenkov IuN; Privalova EV; Chekneva IS; Zheleznych EA; Khiazeva LV; Azizova OA; Aseĭchev AV; Baranova OA; Shvachko AG
    Kardiologiia; 2011; 51(1):5-10. PubMed ID: 21626795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of metabolic factors on the vasorelaxation endothelial function in patients with type II diabetes and arterial hypertension].
    Demidova TIu; Ametov AS; Smagina LV
    Klin Med (Mosk); 2005; 83(10):25-30. PubMed ID: 16320841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in metabolic and vascular disorders.
    Polovina MM; Potpara TS
    Postgrad Med; 2014 Mar; 126(2):38-53. PubMed ID: 24685967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes on postinfarction heart failure and left ventricular remodeling.
    von Bibra H; St John Sutton M
    Curr Heart Fail Rep; 2011 Dec; 8(4):242-51. PubMed ID: 21842146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure.
    Miche E; Herrmann G; Nowak M; Wirtz U; Tietz M; Hürst M; Zoller B; Radzewitz A
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i117-24. PubMed ID: 16598538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular dysfunction in metabolic disorders: evaluation of some therapeutic interventions].
    Bouskela E; Kraemer de Aguiar LG; Nivoit P; Bahia LR; Villela NR; Bottino DA
    Bull Acad Natl Med; 2007 Mar; 191(3):475-92; discussion 492-3. PubMed ID: 18072649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of hypertension in diabetes.
    Stas SN; El-Atat FA; Sowers JR
    Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of propranolol on the indicators of carbohydrate metabolism and lipid transport in patients with diabetes mellitus type 2].
    Filatova NP; Ostrovskaia TP; Novikov AV; Iliushina IP; Olfer'ev AM
    Probl Endokrinol (Mosk); 1988; 34(1):5-9. PubMed ID: 3283727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of insulin resistance in the pathogenesis of sarcopenia and chronic heart failure in elderly hypertensive patients].
    Gorshunova NK; Medvedev NV
    Adv Gerontol; 2016; 29(2):324-328. PubMed ID: 28514553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between insulin resistance and endotheliopathy.
    Tooke J
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S17-22. PubMed ID: 11220284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [State of microcirculation and endothelial dysfunction in patients with type 2 diabetes mellitus and arterial hypertension].
    Volkov VS; Rudenko EV
    Klin Med (Mosk); 2008; 86(3):41-3. PubMed ID: 18441703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.